院士风采
 宋恭华
 施小新
 崔景斌
 高峰
 景秋芳
 任福正
 段梅莉
 冀亚飞
 刘宏伟
 罗晓燕
 马红梅
 虞心红
 翁伟宇
 徐仲玉
 吕霞
 周翾
 王越
 唐赟
 邓卫平
 黄瑾
 李剑
 杨弋
 曾步兵
 刘建文
 刘桂霞
 郑文云
 马磊
 段文虎
 胡立宏
 李晓东
 周岚
 姚蕾
 陈芳
 牛婧
 韩伟
 王春丽
 李忠
 徐玉芳
 朱维平
 彭延庆
 黄青春
 徐晓勇
 曹松
 程家高
 叶金星
 柯燕雄
 刘仁华
 梁鑫淼
 顾江萍
 褚长虎
 刘慧
 须志平
 石慧
 张敏
 李洪林
 金郁
 蒋华良
 熊志奇
 AP de Silv
 Sangho Koo
 沈旭
 钱旭红
 任德权
 沈寅初
 陈卫东
 郑静
 朱进
 邵旭升
 王苏莉
 杨丙成
 章飞芳
 王蕊
 李卫华
 吴连弟
 张卫东
 杨友
 赵玉政
 谢贺新
 杨有军
 梁欣
 余星昕
 杨泱泱
 肖云盼
 李浩
 任国宾
 付建军
 何薇薇
 朱丽丽
 楼开炎
 陶黎明
 赵建宏
 赵振江
 徐文平
 胡泽岚
 殷伟
 许舒雯
 张永强
 张青
 陈显军
 徐缓
 陈卓
 陈晓蓓
 陈彦佐
 傅青
 洪鸣凰
 刘岩
 毛斐
 齐明辉
 任江萌
 刁妍妍
 刘朝阳
 陆佳妮
 马小思
 孙仲颖
 徐蓓玲
 魏金莲
 王佳毅
 邵桐
 秦诚
 李晓康
 吴曾睿
 蒋威
 盛春泉
 张大生
 徐文
 张阳
 李诗良
 邹春城
 杨武林
 朱彬
 孙君江
 王傲雪
 李婷
 李写
 张辰
 吴侠
 程侠卫
 苏倪
 马跃跃
 罗艳霞
 贺牧野
 李新明
 张绍进
 黄运远
 徐以香
 万年峰
 慕欣
 张健
 郑军
 黄守城
 付稳
 蒋玉辉
 周聪

 

 

 

 

 

 

 

 

 

 

 

 

洪鸣凰

副研究员

联系信息

  • 办公室:实验十八楼333

  • Email: mhhong@ecust.edu.cn

  • 电话: +86 21 6425 2579

  • 传真: +86 21 6425 3406

教育经历

  • 2009.06 复旦大学药学院 理学博士

  • 2004.06  复旦大学药学院 理学学士

工作经历

  • 2014.01-       华东理工大学药学院  副研究员

  • 2010.08-2013.12    上海医药工业研究院  副研究员

  • 2009.07-2010.07  上海开拓者医药发展有限公司 研究员

研究方向

第一部分  工业药学——处方前研究和制剂学研究

研究方向:1. 药物晶型研究,包括晶型筛选、盐型筛选、共晶、离子液体、固态表征及质量标准制定

                    2. 固体药物制剂开发

                    3. 制剂研发中的晶型问题,包括制剂中药用晶型的判定、晶型转化及质量标准

第二部分 基础研究——肿瘤靶向纳米载药系统

研究方向:以纳米载药系统(包括脂质体、纳米粒、非粒子表面活性剂泡囊和共轭物)为载体,将抗肿瘤药物递送至肿瘤部位而实现靶向治疗。

发表文章

  1. Hao Wu, Zhaizhu Deng, Bijian Zhou, Minghui Qi, Minghuang Hong, Guobin Ren. Improved transdermal permeability of ibuprofen by ionic liquid technology: Correlation between counterion structure and the physicochemical and biological properties, J. Mol. Liq., 2019, 283:399-409.

  2. Minghuang Hong, Sai Guo, Kai Wang, Lei Ma, Guobin Ren, Influence factor investigation on the solution-mediated polymorphic transformation of Baricitinib phosphate, Z. Anorg. Allg. Chem., 2018, 644:849-855.

  3. Minghuang Hong#, Jingyan Chen#, Hui Zhou, Hao Xu, Guobin Ren, Investigation of a solution-mediated phase transformation of pranlukast DMF solvate to hemihydrate, Cryst. Res. Technol., 2017, 52(6): 1700045.

  4. Minghuang Hong#, Shiwang Wu#, Minghui Qi, Guobin Ren, Solubility correlation and thermodynamic analysis of two forms of metaxalone in different pure solvents, Fluid Phase Equilib., 2016, 409: 1-6.

  5. Ming-Hui Qi#, Ming-Huang Hong#, Yan Liu, En-Fu Wang, Fu-Zheng Ren, Guo-Bin Ren, Estimating thermodynamic stability relationship of polymorphs of sofosbuvir, Cryst. Growth Des., 2015, 15(10): 5062-5067.

  6. Minghuang Hong#, Lehui Xu#, Guobin Ren, Jinyao Chen, Minghui Qi, Solubility of lansoprazole in different solvents, Fluid Phase Equilib., 2012, 331: 18-25.

  7. Minghuang Hong, Saijie Zhu, Yanyan Jiang, Guotao Tang, Chang Sun, Chao Fang, Bin Shi, and Yuanying Pei, Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles, J Control Release, 2010, 141: 22-29.

  8. Minghuang Hong, Saijie Zhu, Yanyan Jiang, Guotao Tang, and Yuanying Pei, Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin, J Control Release,2009,133, 96-102.

  9. Guo-Bin Ren, Ming-Huang Hong, Jia-Liang Zhong, Dong-Xu Yi, Le-Hui Xu, 2-{[3-Methyl-4-(2,2,2-trifluoroethoxy)-pyridin-2-yl]methylsulfanyl}-1H-benzimidazole monohydrate, Acta Cryst., 2011, E67: o270.

  10. Saijie Zhu, Minghuang Hong, Guotao Tang, Lili Qian, Jiayuan Lin, Yanyan Jiang, and Yuanying Pei, Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation style, Biomaterials, 2010, 31: 1360-1371.

  11. Saijie Zhu, Minghuang Hong, Lihong Zhang, Guotao Tang, Yanyan Jiang, and Yuanying Pei, PEGylated PAMAM dendrimer-doxorubicin conjugates: in vitro evaluation, and in vivo tumor accumulation, Pharm. Res-Doror., 2010, 27: 161-173.

  12. Saijie Zhu, Minghuang Hong, Chen Liu, and Yuanying Pei, Application of Box-Behnken design in understanding the quality of genistein self-nanoemulsified drug delivery systems and optimizing its formulation. Pharm. Dev. Technol., 2009, 14, 642-649.

  13. Jinju Ma, Ming-Hui Qi, Ming-Huang Hong, Jie Lu, Guo-Bin Ren, 2-{[3-Methyl-4-(2,2,2-trifluoroethoxy)-pyridin-2-yl]methylsulfanyl}-1H-benzimidazole propan-2-ol monosolvate: a second monoclinic polymorph, Acta Cryst., 2012, E68: o2017

  14. Yu-Feng Chen, Jin-Yao Chen, Ming-Huang Hong, Jie Lu, Guo-Bin Ren, 2-{[3-Methyl-4-(2,2,2-trifluoroethoxy)-pyridin-2-yl]methylsulfanyl}-1H-benzimidazole monohydrate: a monoclinic polymorph, Acta Cryst., 2012, E68: o2015-o2016

  15. Wenhua Chen, Ne Guo, Minghui Qi, Haiying Dai, Minghuang Hong, Longfei Guan, Xiajuan Huan, Shanshan Song, Jinxue He, Yingqing Wang, Yong Xi, Xinying Yang, Yanyan Shen, Yi Su, Yiming Sun, Yinglei Gao, Yi Chen, Jian Ding, Yun Tang, Guobin Ren, Zehong Miao, Jian Li,Discovery, mechanism and metabolism studies of 2,3-difluorophenyl-linker-containing PARP1 inhibitors with enhanced in vivo efficacy for cancer therapy, Eur. J. Med. Chem., 2017, 138: 514-531

  16. Saijie Zhu, Lili Qian, Minghuang Hong, Lihong Zhang, Yuanying Pei, and Yanyan Jiang, RGD-Modified PEG-PAMAM-DOX Conjugate: In vitro and in vivo targeting to both tumor neovascular endothelial cells and tumor cells. Adv. Mater., 2011, 23: 84-89.

  17. Saijie Zhu, Rongqin Huang, Minghuang Hong, Yanyan Jiang, Zhuohan Hu, Chen Liu, Yuanying Pei, Effects of polyoxyethylene (40) stearate on the activity of P-glycoprotein and cytochrome P450. Eur. J Pharm. Sci., 2009, 37: 573-580.